What is food as medicine (FAM)?

Food as medicine is a clinical category that covers medically tailored meals (MTM), medically tailored groceries, produce prescriptions, and RDN-led nutrition counseling, delivered to chronically-ill patients with documented condition-specific dietary requirements.

Why are payers funding food as medicine in 2026?

Four forces converged: GLP-1 spend management, SSBCI evidence requirements post-VBID, the Stars HEI bonus, and 1115 Medicaid waivers.

The 2026 Payer Inflection: Why Food as Medicine is No Longer Optional

The direct answer

Four convergent forces have moved Food as Medicine (FAM) from a wellness pilot to a core actuarial necessity: (1) The "GLP-1 Budget Cliff" requiring adjunctive nutrition for sustained efficacy; (2) The VBID-to-SSBCI transition requiring rigorous evidence standards; (3) The CY2027 Stars Health Equity Index (HEI) bonus; and (4) 1115 Medicaid waivers. FAM is the most efficient lever to move all four simultaneously.

Frequently asked

What is food as medicine (FAM)?: Food as medicine is a clinical category that covers medically tailored meals (MTM), medically tailored groceries, produce prescriptions, and RDN-led nutrition counseling, delivered to chronically-ill patients with documented condition-specific dietary requirements.
Why are payers funding food as medicine in 2026?: Four forces converged: GLP-1 spend management, SSBCI evidence requirements post-VBID, the Stars HEI bonus, and 1115 Medicaid waivers.

As we enter the 2026-2027 plan year, the healthcare landscape has shifted. The novelty of "food as a benefit" has been replaced by the necessity of "nutrition as a clinical protocol." For payers, the focus is now on three specific areas of impact:

1. The GLP-1 Complement

With GLP-1 pharmacy spend reaching sustainable limits, plans are discovering that the medication alone is not a "magic bullet." Without medically tailored nutrition to manage muscle mass preservation and behavioral habit-stacking, "rebound spend" occurs when medication is titrated. RxPulse provides the nutritional scaffolding that makes GLP-1 investments durable.

2. The Stars HEI Bonus (CY2027)

The new Health Equity Index (HEI) bonus doesn't just reward high performance; it rewards the closure of health-related social needs (HRSN). By integrating the Allie companion with medically tailored meal delivery, plans can document HRSN closure in real-time, directly impacting their QBP (Quality Bonus Payment) revenue.

3. SSBCI Evidence Rigor

Post-VBID sunset, CMS now requires documented evidence that SSBCI benefits have a "reasonable expectation" of improving health. RxPulse generates this evidence through the "Allie Feedback Loop," providing plans with the longitudinal data required to defend their benefit designs during audit.

The Strategic Recommendation

We recommend a "Condition-First" deployment strategy. Rather than broad-based grocery allowances which lack clinical steering, plans should deploy Medically Tailored Grocery (MTG) and companion support specifically for high-risk cohorts—CHF, CKD, and Diabetes—where the medical-cost offset is most immediate and measurable.

30-minute walkthrough

Want this in your population? Let’s walk through it.

We’ll cover the outcome evidence, member journey, and interop surface — with clear next steps for your committee or bid team.

Schedule a call More insights

Editorial. This content is reviewed per our editorial policy. Commercial COI: RxPulse + RxDiet provide food-as-medicine services and an AI companion platform. Clinical recommendations are evidence-anchored.